ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Menlo Therapeutics Inc

Menlo Therapeutics Inc (MNLO)

1.35
0.00
(0.00%)
Cerrado 23 Noviembre 3:00PM
0.00
0.00
(0.00%)
Fuera de horario: -

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
1.35
Postura de Compra
1.36
Postura de Venta
1.37
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
Precio Anterior
1.35
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
13,957,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-1.49
Beneficio por acción (BPA)
-2.04
turnover
424k
Beneficio neto
-28.45M

Acerca de Menlo Therapeutics Inc

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sede
Wilmington, Delaware, USA
Fundado
-

MNLO Últimas noticias

Robbins Geller Rudman & Dowd LLP Announce Proposed Settlement in the Menlo Therapeutics Inc. Securities Settlement

The following statement is being issued by Robbins Geller Rudman & Dowd LLP regarding the Menlo Therapeutics Inc. Securities Settlement: SUPERIOR COURT OF THE STATE OF CALIFORNIA COUNTY OF...

Menlo Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results

REDWOOD CITY, Calif., March 03, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the...

Menlo Therapeutics Announces Results from Phase 2 Trial of Serlopitant in Patients with Chronic Pruritus of Unknown Origin

REDWOOD CITY, Calif., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company, today announced results from its Phase 2 clinical trial...

Menlo Therapeutics to Host Conference Call Tomorrow to Discuss Results from Phase 2 Trial of Serlopitant in Patients with Chr...

REDWOOD CITY, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company, today announced it will host a conference call and webcast...

Menlo Therapeutics Announces Publication of Phase 2 Results for Serlopitant for the Treatment of Pruritus Associated with Pso...

REDWOOD CITY, Calif., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment...

Menlo Therapeutics CEO to Participate in Fireside Chat at the Piper Jaffray 31st Annual Healthcare Conference

REDWOOD CITY, Calif., Nov. 27, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment...

SHAREHOLDER ALERT: WeissLaw LLP Investigates Foamix Pharmaceuticals Ltd.

SHAREHOLDER ALERT: WeissLaw LLP Investigates Foamix Pharmaceuticals Ltd. PR Newswire NEW YORK, Nov. 12, 2019 NEW YORK, Nov. 12, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible...

Menlo Therapeutics Reports Third Quarter 2019 Financial Results and Provides Program Updates

REDWOOD CITY, Calif., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment...

Menlo Therapeutics Announces Completion of Enrollment in Two Phase 3 Trials of Serlopitant in Prurigo Nodularis

- Pivotal results expected in March/April 2020 - - Details of the program to be reviewed at company’s Investor Day today in NY - REDWOOD CITY, Calif., Oct. 29, 2019 (GLOBE NEWSWIRE) -- Menlo...

Menlo Therapeutics to Host Investor Day October 29, 2019

-Management to Review Late Stage Development, NDA-readiness and Commercial Opportunity of Serlopitant- -Discussion to Feature two Prominent Key Opinion Leaders Well Versed in the Unmet Needs of...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
PDYNPalladyne AI Corporation
US$ 4.59
(129.50%)
83.07M
QMCOQuantum Corporation
US$ 9.11
(126.62%)
39.48M
NANano Labs Ltd
US$ 8.26
(89.02%)
2.03M
XCURExicure Inc
US$ 18.60
(71.27%)
4.59M
SKKSKK Holdings Limited
US$ 1.75
(59.09%)
107.47M
AMIXAutonomix Medical Inc
US$ 6.21
(-54.07%)
946.09k
CETXCemtrex Inc
US$ 0.1146
(-41.74%)
24.39M
MSWMing Shing Group Holdings Ltd
 5.90
(-35.52%)
417.08k
RMSGReal Messenger Corporation
US$ 3.09
(-26.25%)
313.51k
ENSCEnsysce Biosciences Inc
US$ 0.4414
(-25.49%)
4M
ELABElevai Labs Inc
US$ 0.0201
(-0.50%)
425.38M
NVDANVIDIA Corporation
US$ 141.95
(-3.22%)
236.51M
SMCISuper Micro Computer Inc
US$ 33.15
(11.62%)
159.61M
VRPXVirpax Pharmaceuticals Inc
US$ 0.5501
(-6.72%)
159.39M
SOUNSoundHound AI Inc
US$ 8.24
(18.05%)
107.91M
BDEZ BDEZ 7 minutos hace
Good to know re: Pam Bondi...
WooptdooU WooptdooU 8 minutos hace
Mr Jim Cramer calls it "an experiment". eom
LWLG
The Night Stalker The Night Stalker 9 minutos hace
https://www.stockscores.com/charts/charts/?ticker=aunxf
AUNXF
WooptdooU WooptdooU 10 minutos hace
INSIDERS BUY NO SHARES with their own money!!! Full period, stop.
LWLG
Kool Aid Man Kool Aid Man 10 minutos hace
It's a common name --no known/published contact info anywhere. Does he even exist? He doesn't appear in OTC's service providers list though thousands do.

Searchable list: https://www.otcmarkets.com/learn/service-providers

However, Gary L. Blum does--23 total. Where you
BIEI FMNJ GRPS
tdbowieknife tdbowieknife 10 minutos hace
In case ya missed the news.... Klug won't tell ya.

https://drive.google.com/file/d/1WilTlgf0W8Vp1kFvyooUsg71qU2r1xlO/view


..


.
BDEZ BDEZ 11 minutos hace
Politico is reporting that Communist AGs are preparing a “raft of legal actions” to prevent President Trump from carrying out mass deportations

https://x.com/DefiyantlyFree/status/1860534756787589511
Investor082 Investor082 12 minutos hace
Agreed. NWBO has had a rich history of dangling carrots, changing course, and screwing investors. Don’t trust it until there is large upfront cash involved.

Besides, no big pharma would allow such behavior where the small company gets ahead of them and starts talking about partnershi
NWBO
Kaiserwave Kaiserwave 12 minutos hace
Is it time to drop a zero yet. I wanna go back to 30s and establish new highs. Ughg so excited. Let's freaking go.
RDAR
The Night Stalker The Night Stalker 13 minutos hace
break 002 it can be big
AUNXF
JJ8 JJ8 14 minutos hace
That chart is not looking too good to me.

The decline of the volume is not a good sign.

Could it be temporary?

We hope so.

Talk about 2030 is something else.

To me it sounds a bit like a lullaby.

A lot of p
NVDA
The Night Stalker The Night Stalker 15 minutos hace
one day
IGEX
The Night Stalker The Night Stalker 18 minutos hace
https://www.stockscores.com/charts/charts/?ticker=otlc
OTLC
1vman 1vman 19 minutos hace
***** No !!! 🚽UBQU🚽 Does not have 5 million in revenues , point in fact financials are not very good

ENOUGH SAID HUZZAH🤪 !!!
UBQU
1vman 1vman 20 minutos hace
*****🟥🟥🟥 Short story long 🚽DBMM🚽 is a failing company for 20 years thats going down hill fast ! -- Wh👀ps !

ENOUGH SAID HUZZAH🤪 !!!
DBMM
BDEZ BDEZ 20 minutos hace
Mexico is dumping their black water in to our country

https://x.com/AgueroForTexas/status/1860497173168947254
1vman 1vman 21 minutos hace
***** LOL ! 🚽HCMC🚽 4point plan ??? Notice near the bottom they indicate the following - just more OTC stinky pinky nonsense - Wh👀ps


In addition, when used in this release, the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” and “plan
HCMC
BDEZ BDEZ 23 minutos hace
Uganda targets 2027 start for world’s longest heated oil pipeline

https://www.ft.com/content/061f0636-c868-4c8e-93f1-89a9e0a8f486
StayHumble StayHumble 24 minutos hace
Yes! $UBQU✅IO does $5M🍁inRevenue Annually+Growing✅ ✅w/Facilities already in place to help make it happen. Just watch what we do!
https://x.com/CorporateUbqu/status/1767983893544566905?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1767983893544566905%7Ctwgr
UBQU
The Night Stalker The Night Stalker 26 minutos hace
2025 winner
AAGC
EternalPatience EternalPatience 27 minutos hace
When is Bessent sighting on Fox business expected?  Mon or Tues?
FNMA
blackhawks blackhawks 28 minutos hace
It's going to be a stroll down cognitive dissonance lane for Trump's supporters; inflation, recession, gays in his administration and abject appeasement of Russia.
back2basics back2basics 28 minutos hace
I've been missing for several days. I had something happen to me that was as serious as a heart attack.

I had a heart attack.

B2B---back home and feeling fine.
StayHumble StayHumble 31 minutos hace
Idiot,inCourtUnderOath💹D0E tried Crying V.$DBMM+Mgmt💹(D0H! Br. at 25-28.)

$DBMM has obtained resources to complete the re-audit, bring the Company current, & continue its timely filings,

DOE once again rejects the Law Judge’s analysis and conclusion th
DBMM

Su Consulta Reciente

Delayed Upgrade Clock